4-(3-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-1H-indazol-5-yl)morpholine

ID: ALA3774744

Chembl Id: CHEMBL3774744

PubChem CID: 127034165

Max Phase: Preclinical

Molecular Formula: C22H23N5O

Molecular Weight: 373.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCOCC5)cc34)cc2)cn1

Standard InChI:  InChI=1S/C22H23N5O/c1-26-15-18(14-23-26)17-4-2-16(3-5-17)12-22-20-13-19(6-7-21(20)24-25-22)27-8-10-28-11-9-27/h2-7,13-15H,8-12H2,1H3,(H,24,25)

Standard InChI Key:  UETJKJCLDAZMNX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3774744

    ---

Associated Targets(Human)

CDK8 Tchem CDK8/Cyclin C (1054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem Cell division protein kinase 8 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.46Molecular Weight (Monoisotopic): 373.1903AlogP: 3.39#Rotatable Bonds: 4
Polar Surface Area: 58.97Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.79CX LogP: 3.23CX LogD: 3.23
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: -1.74

References

1. Schiemann K, Mallinger A, Wienke D, Esdar C, Poeschke O, Busch M, Rohdich F, Eccles SA, Schneider R, Raynaud FI, Czodrowski P, Musil D, Schwarz D, Urbahns K, Blagg J..  (2016)  Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.,  26  (5): [PMID:26852363] [10.1016/j.bmcl.2016.01.062]

Source